Powder: -20°C for 3 years | In solvent: -80°C for 1 year
NCC007 is a novel CKIα and CKIδ dual inhibitors by structural modification of N9 and C2 position of longdaysin.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 34.00 | |
2 mg | In stock | $ 48.00 | |
5 mg | In stock | $ 80.00 | |
10 mg | In stock | $ 122.00 | |
25 mg | In stock | $ 197.00 | |
50 mg | In stock | $ 343.00 | |
100 mg | In stock | $ 513.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 89.00 |
Description | NCC007 is a novel CKIα and CKIδ dual inhibitors by structural modification of N9 and C2 position of longdaysin. |
Targets&IC50 | CKIδ:3.6 μM, CKIα:1.8 μM |
In vitro | In vitro kinase assay showed that NCC007 inhibited CKIα and CKIδ with an IC50 of 1.8 and 3.6 μM. |
In vivo | NCC007 lengthened the period of mouse behavioral rhythms in vivo. |
Molecular Weight | 447.5 |
Formula | C22H28F3N7 |
CAS No. | 2342583-66-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 120 mg/mL (268.16mM), sonification is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
NCC007 2342583-66-6 Metabolism Stem Cells Casein Kinase inhibit NCC-007 Inhibitor NCC 007 inhibitor